Cambridge Enterprise portfolio company Lumora Limited has announced the appointment of Paul Weinberger as Chief Marketing Officer.
Lumora appoints new Chief Marketing Officer
Cambridge Enterprise portfolio company Lumora Limited has announced the appointment of Paul Weinberger as Chief Marketing Officer. Paul will be responsible for Corporate Marketing and Business Development, including licensing and commercial agreements. He brings extensive experience of molecular diagnostics business development from both early-stage and established industry players.
Prior to joining the Lumora team, Paul held senior positions at Roche Diagnostics and Enigma Diagnostics spanning R&D, Business Development and Marketing. He has been responsible for the design and development of a rapid, point-of-care, molecular diagnostic system, and has negotiated and helped execute multiple co-development and marketing agreements. Paul also has extensive experience of introducing novel molecular technologies and tests to the market.
Paul was Chairman of the British In Vitro Diagnostics Association from 2003 to 2006, and is also a founding member of the Diagnostics Advisory Committee recently formed by the UK National Institute of Clinical Excellence (NICE).
“I am delighted to welcome Paul to Lumora” said Dr. Laurence Tisi, CEO, “His extensive molecular diagnostic and Business Development experience will prove invaluable in establishing and implementing Lumora’s commercial strategy. “
Lumora is developing a new generation of molecular diagnostics, initially based on its proprietary Bioluminescent Assay in Real-Time (BART) technology, that are fast, easy-to-use and affordable. BART is a novel reporter system, exclusive to Lumora, designed to be used with isothermal nucleic acid amplification technologies. The simplicity of BART
enables uncomplicated, low-cost, very robust hardware to be used. This is a major break-through as molecular diagnostics are typically associated with complex, fragile and expensive hardware.
Lumora was founded in 2002 by Laurence Tisi and Jim Murray, when it was spun-out from the Institute of Biotechnology at the University of Cambridge. Following two funding rounds, Lumora is seeking partners to bring its core technology to market across multiple sectors.
For more information visit www.lumora.co.uk
Head of Marketing
Cambridge Enterprise Limited
Tel: 01223 760 339
Chief Marketing Officer
Tel: +44 (0)1353 667983
Fax: +44 (0)1353 667938
Cambridge Enterprise Limited, University of Cambridge www.enterprise.cam.ac.uk
Cambridge Enterprise Limited is responsible for the commercialisation of University of Cambridge intellectual property and is a wholly owned subsidiary of the University. Activities include management and licensing of intellectual property and patents, proof of concept funding and support for University staff and research groups wishing to provide expert advice or facilities to public and private sector organisations. Cambridge Enterprise provides access to angel and early stage capital through the Cambridge Enterprise Seed Funds and Cambridge Enterprise Venture Partners, and offers business planning, mentoring and other
The University leads the world in transformative research and Cambridge Enterprise is well placed to support the academics to find the best commercialisation route for their innovations either through licensing, company creation or consultancy. Income over the past two years exceeded £18 million, of which almost £14 million was distributed to University academics and departments, with the remainder reinvested in patent assets, seed fund pools and support for knowledge and technology transfer services to the University.
Cambridge Enterprise exists to help University of Cambridge inventors, innovators and entrepreneurs make their ideas and concepts more commercially successful for the benefit of society, the UK economy, the inventors and the University.